Calumenin may also interact with serum amyloid P component (SAP), a glycoprotein mainly synthesized in the liver, and may participate in the immunological defense system and be involved in the pathological process of amyloidosis that leads to formation of amyloid deposits seen in different types of tissues [46]. Here, CALU is linked to amyloidosis.